CSIMarket
 


Nuo Therapeutics Inc   (NUOT)
Other Ticker:  
 

Cumulative Nuo Therapeutics Inc 's Leverage Ratio for Trailing Twelve Months Period

NUOT's Leverage Ratio for Trailing Twelve Months Period and Total Liabilities, Equity growth


Select the Comparisons : Select the Ratio:

NUOT Leverage Ratio for Trailing Twelve Months Period

(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Equity Growth -76.93 % -86.78 % 153.78 % 176.39 % -
Y / Y Total Liabilities Growth 22.27 % 20.14 % 66.26 % 27.18 % 6.19 %
Leverage Ratio for Trailing Twelve Months Period 0.75 0.47 0.31 0.3 0.33
Total Ranking # 1367 # 1006 # 742 # 858 # 906
Seq. Equity Growth 54.35 % -64.81 % -38.94 % -30.45 % -11.55 %
Seq. Total Liabilities Growth -4.51 % 3.59 % 3.13 % 19.87 % -6.17 %


Leverage Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Sep 30 2023
On the trailing twelve months basis Despite debt repayement of -4.51% in III. Quarter, Leverage Ratio for Trailing Twelve Months Period improved to 0.75, below Nuo Therapeutics Inc 's average Leverage Ratio for Trailing Twelve Months Period.
Leverage Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Medical Equipment & Supplies industry 134 other companies have achieved lower Leverage Ratio for Trailing Twelve Months Period than Nuo Therapeutics Inc . While total ranking remained unchanged compare to previous quarter at no. .

What is Leverage Ratio?
Who are NUOT's Customers?
Leverage Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 135
Sector # 641
S&P 500 # 1983


Leverage Ratio for Trailing Twelve Months Period Statistics
High Average Low
19.44 2.61 0.14
(Dec 31 2016)   (Mar 31 2017)




Companies with similar average Leverage Ratio for Trailing Twelve Months Period for 12 months ending Sep 30 2023, within Medical Equipment & Supplies Industry Leverage Ratio for Trailing Twelve Months Period
Tela Bio Inc   2.04 
Vaso Corporation  2.04 
Apollo Endosurgery inc   2.02 
Conmed Corporation  1.94 
Transmedics Group Inc   1.94 
Petvivo Holdings Inc  1.89 
Artivion Inc   1.80 
Dexcom Inc   1.79 
Strata Skin Sciences Inc   1.71 
Msa Safety Incorporated  1.64 
Patterson Companies Inc   1.63 
Pulse Biosciences Inc   1.63 
Iridex Corp  1.62 
Pear Therapeutics Inc   1.59 
Novocure Limited  1.59 
Tandem Diabetes Care Inc   1.48 
Therapeutic Solutions International Inc   1.42 
Orchestra Biomed Holdings Inc   1.40 
Eargo Inc   1.40 
Masimo Corp  1.37 
Intelligent Bio Solutions Inc   1.30 
Cadre Holdings Inc   1.29 
Nuvasive Inc  1.28 
U S Physical Therapy Inc  1.27 
Ss Innovations International Inc   1.26 
Haemonetics Corporation  1.23 
Stryker Corp  1.19 
Zimvie Inc   1.16 
Carlisle Companies Incorporated  1.13 
Zynex inc   1.11 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com